Long intergenic non-protein coding RNA 539 (LINC00539)

Long intergenic non-protein coding RNA 539 (LINC00539) is a human long non-coding RNA gene (HGNC:4367, Ensembl: ENSG00000224429) that does not encode a protein but instead regulates gene expression and cellular behavior through RNA-mediated mechanisms[1][5][7]. LINC00539 is upregulated in glioma and correlated with aggressive disease features such as vasculogenic mimicry – the ability of cancer cells to form vessel-like structures independent of classical angiogenesis. Mechanistically, LINC00539 acts as a competing endogenous RNA (molecular sponge) to modulate miR-539-5p levels, thereby indirectly regulating key oncogenic factors such as TWIST1 and matrix metalloproteinases (MMP-2, MMP-14), contributing to tumor proliferation, migration, invasion, and tube formation[2]. While not a direct therapeutic target in current clinical practice, LINC00539 may represent a candidate for future RNA-based interventions and a biomarker for glioma progression.

Other names

LINC00539LINC00422Long intergenic non-protein coding RNA 422HSALNG0095595

Not applicable (no direct drugs known). For lncRNA-based intervention, typical mechanisms would include antisense oligonucleotides, RNA interference, or targeted gene editing. For LINC00539, functional modulation would likely involve altering its expression or interfering with its ability to act as a molecular sponge for specific miRNAs (e.g., miR-539-5p)